BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31957815)

  • 1. MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2.
    Wang F; Zhao QH; Liu JZ; Kong DL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):29-35. PubMed ID: 31957815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-449b-5p Suppresses Proliferation, Migration, and Invasion of Osteosarcoma by Targeting c-Met.
    Li Q; Lu C; Wang J; Gao M; Gao W
    Med Sci Monit; 2019 Aug; 25():6236-6243. PubMed ID: 31425497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated miRNA-1236-3p in osteosarcoma inhibits cell proliferation and induces apoptosis via targeting KLF8.
    Sun Y; Cao L; Lin JT; Yuan Y; Cao ZL; Jia JD
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6053-6061. PubMed ID: 31364106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-150-5p inhibits proliferation and invasion of osteosarcoma cells by down-regulating VEGFA.
    Qin Y; Zhang B; Ge BJ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9265-9273. PubMed ID: 33015767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-98-5p inhibits the progression of osteosarcoma by regulating cell cycle via targeting CDC25A expression.
    Liu X; Cui M
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9793-9802. PubMed ID: 31799646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
    Yin Z; Ding H; He E; Chen J; Li M
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-183-5p suppresses the malignant progression of osteosarcoma via binding to AKT.
    Shao JH; Yuan S; Qian QR; Zhu J
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8203-8210. PubMed ID: 31646550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-206 suppresses the metastasis of osteosarcoma via targeting Notch3.
    Cai WT; Guan P; Lin MX; Fu B; Wu B; Wu J
    J Biol Regul Homeost Agents; 2020; 34(3):775-783. PubMed ID: 32627519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
    Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
    Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
    Li J; Wang AS; Wang S; Wang CY; Xue S; Guan H; Li WY; Ma TT; Shan YX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1022-1029. PubMed ID: 30779068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-299-5p targets cell cycle to promote cell proliferation and progression of osteosarcoma.
    Zhang CL; Li LB; She C; Xie Y; Ge DW; Dong QR
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2606-2613. PubMed ID: 29771409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-497-5p Suppresses Tumor Cell Growth of Osteosarcoma by Targeting ADP Ribosylation Factor-Like Protein 2.
    Sun Z; Li A; Yu Z; Li X; Guo X; Chen R
    Cancer Biother Radiopharm; 2017 Dec; 32(10):371-378. PubMed ID: 29265919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2.
    Wu H; Yu Z; Chen Q; Li D; Chen W
    J BUON; 2020; 25(2):1013-1021. PubMed ID: 32521900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia.
    Liu YY; Jiao WY; Li T; Bao YY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8468-8475. PubMed ID: 31646577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1.
    Qu Q; Chu X; Wang P
    Cell Biol Int; 2017 Mar; 41(3):287-295. PubMed ID: 28032380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
    Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.